ARCHIVES

Genentech Reps Not Welcome: Hospitals Urge Drug Maker to Reverse Policy On Supplying Avastin, Rituxan, & Herceptin

This article is from The Cancer Letter archive.

Vol. 40 No. 39 | October 17, 2014

Download PDF Visit The Full Archive

Related Articles

In Brief: Use More Ad Hoc Committees For Grants, Look At Number, Distribution Of Centeres: Katterhagen

August 28, 1981

New Law Allows Texans To Self-Refer To M.D. Anderson

December 1, 1995

Phase III PANORAMA-1 Trial Meets PFS Primary Endpoint

June 27, 2014

Reagan Signs Skins Cancer Resolution

March 29, 1985

Abstracts Deadline For Cancer Congress Extended To Dec. 31

December 13, 1985

NIH Dedicates Louis Stokes Laboratories; Royston Retires As Kimmel Center President.

June 22, 2001